PerkinElmer Introduces Novel Life Sciences Solutions at the Society for Laboratory Automation and Screening (SLAS) 2013

  PerkinElmer Introduces Novel Life Sciences Solutions at the Society for
  Laboratory Automation and Screening (SLAS) 2013 Conference

 Enhanced tools and expanded epigenetic kits help in the advancement of drug
                           development and research

SLAS 2013

Business Wire

ORLANDO, Fla. -- January 10, 2013

PerkinElmer, Inc., a global leader focused on improving the health and safety
of people and the environment, will showcase an array of novel products at the
2^nd Annual Society for Laboratory Automation and Screening (SLAS) Conference
(#SLAS2013) in Orlando, January 12-16, including an Epigenetic Biochemical
Toolbox, the JANUS^® NGS Express™ liquid handling workstation and the
Sciclone^® NGSx Workstation™ platform (booth #1207).

The PerkinElmer JANUS(R) NGS Express(TM) liquid handling workstation automates
key procedures involv ...

The PerkinElmer JANUS(R) NGS Express(TM) liquid handling workstation automates
key procedures involved in the sample preparation workflow for benchtop
next-generation DNA sequencing platforms. (Photo: Business Wire)

“We are excited to participate in this significant industry event and bolster
our commitment to our customers with new and transformational innovations that
will help them to advance the prevention, detection and treatment of disease,”
said Kevin Hrusovsky, president, Life Sciences and Technology, PerkinElmer.
“The study of epigenetics and the exciting innovations in next generation
sequencing are proving to be powerful tools for better understanding cancer
and other debilitating diseases so that we are better equipped to combat them.
We believe our transformative assays and instrumentation will help enable our
customers to bring better, more effective medicines to market.”

PerkinElmer products on display at SLAS 2013 include:

  *An expanded Epigenetic Biochemical Toolbox with more than 40 validated
    enzymatic assays for the detection of post-translational modifications of
    histones H3, H4 and p53. The PerkinElmer assays cover all the major writer
    and eraser enzyme families and can be used across a range of substrates,
    from peptides to histones to full nucleosomes. The toolbox complements the
    novel AlphaLISA^® Epigenetic Cellular Detection Kits for cell-based
    detection of epigenetic modifications. Together, these products allow
    interrogation of compounds in more biologically relevant formats and
    improve efficiency in the identification of drug candidates targeting
    epigenetic enzymes related to key disease states.

    PerkinElmer’s epigenetic portfolio provides researchers access to fully
    validated reagents and assay development services that offer valuable time
    savings in the race to discover novel drug candidates. These highly
    specific reagents along with PerkinElmer’s knowledgeable support for the
    development of epigenetic assays help researchers identify and
    characterize their lead compounds more quickly and efficiently.

  *The PerkinElmer JANUS^® NGS Express™ liquid handling workstation automates
    key procedures involved in the sample preparation workflow for benchtop
    next-generation DNA sequencing platforms. Validated methods include
    fragment library preparation, amplicon sequencing, normalization and
    complex sample pooling for multiplexed sequencing experiments. The JANUS
    NGS Express enables better sample-to-sample consistency and decreased
    hands-on time with the capability of efficient sample preparation of up to
    24 libraries for higher quality library prep with increased yields and
    fewer errors.
  *The PerkinElmer Sciclone^® NGSx Workstation™ platform for high-throughput
    next generation sequencing workflows helps researchers accelerate the
    preparation of DNA samples for sequencing with minimal user intervention.
    The Sciclone NGSx, allows for full walk-away library prep for up to 96
    samples per run with standardized protocols available for exome capture,
    RNA-Seq and fragment library prep using kits from multiple suppliers.
    Automated sample prep with the Sciclone NGSx helps provide consistency,
    repeatability and traceability, eliminate cross-contamination and has the
    flexibility for future application development enabling consistency,
    robustness and the ability to utilize the chemistry of your choice.
  *PerkinElmer offers a full sequencing portfolio dedicated to helping meet
    scientific challenges including sample isolation, fragment and sizing,
    library generation, sample quantification, sequencing and analysis.

The above products are for research use only and not for use in diagnostic
procedures.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The company reported revenue of
approximately $1.9 billion in 2011, has about 7,400 employees serving
customers in more than 150 countries, and is a component of the S&P 500 Index.
Additional information is available through 1-877-PKI-NYSE, or at
www.perkinelmer.com.

Photos/Multimedia Gallery Available:
http://www.businesswire.com/multimedia/home/20130110006299/en/

Multimedia
Available:http://www.businesswire.com/cgi-bin/mmg.cgi?eid=50528460&lang=en

Contact:

Edelman (On behalf of PerkinElmer, Inc.)
Paul Barren, 404-460-9679
paul.barren@edelman.com